<code id='712CC2C68C'></code><style id='712CC2C68C'></style>
    • <acronym id='712CC2C68C'></acronym>
      <center id='712CC2C68C'><center id='712CC2C68C'><tfoot id='712CC2C68C'></tfoot></center><abbr id='712CC2C68C'><dir id='712CC2C68C'><tfoot id='712CC2C68C'></tfoot><noframes id='712CC2C68C'>

    • <optgroup id='712CC2C68C'><strike id='712CC2C68C'><sup id='712CC2C68C'></sup></strike><code id='712CC2C68C'></code></optgroup>
        1. <b id='712CC2C68C'><label id='712CC2C68C'><select id='712CC2C68C'><dt id='712CC2C68C'><span id='712CC2C68C'></span></dt></select></label></b><u id='712CC2C68C'></u>
          <i id='712CC2C68C'><strike id='712CC2C68C'><tt id='712CC2C68C'><pre id='712CC2C68C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:72185

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Shionogi licenses Pompe disease therapy from Maze Therapeutics
          Shionogi licenses Pompe disease therapy from Maze Therapeutics

          MazeTherapeuticsCEOJasonColomaCourtesyAfterseeingitslastdealgobustinthefaceofregulatoryscrutiny,Maze

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Brain worms: The science behind RFK Jr.'s parasitic infection

          RobertKennedy,Jr.toldTheNewYorkTimesawormdiedinhisbrainandcausedneurologicalsymptoms.JOSHEDELSON/AFP